SB was right about the "next layoff won't get a package." Now they're just overtly harassing people they want to leave until they finally do leave. No package. Just get-out or be prepared to be mirco'd out. Huge turnover and it's not half-over yet.
Plans are being drawn up to begin the downsizing. This will be done on coordination with the buyout of Biogen. Look towards 15-20% sales force elimination along with 25% shared services (marketing, HR, training, etc). Deal should be completed by Q4 2016.
OBU to downsize with the buyout of Medivation. Amgen is looking into Biogen as it sees synergy with the MS franchise and 334 and it is opening up to expanding the inflammation franchise beyond Rheumatology. The two acquisitions sets Amgen to be a leader in inflammation and therapeutic oncology to keep up with Abbbie, JnJ and Celgene